Kriya Therapeutics is a gene therapy company. It is focused on designing and developing transformative treatments. Kriya Therapeutics' initial pipeline includes multiple AAV-based gene therapies for the treatment of metabolic diseases including type 1 diabetes, type 2 diabetes, and severe obesity.